IP Library › Assignment 059121/0909
Patent Assignment
Reel/Frame 059121/0909

Assignment of Assignor's Interest

Recorded: 2022-02-28 Pages: 5
Assignor
ZANDER THERAPEUTICS INC.
Executed: 2022-02-28
Assignee
ZANDER BIOLOGICS INC.
4700 SPRING ST, SUITE 304, LA MESA, CALIFORNIA, 91942
Covered Properties (4)
Small Molecule Agonists and Antagonists of NR2F6 Activity
Application: 16/008,526 →
Publication: US 2018/0346456
Small Molecule Agonists and Antagonists of NR2F6 Activity in Animals
Application: 16/008,631 →
Publication: US 2018/0346455
Canine Autologous Immunotherapy Using Dendritic Cell Induced Cancer Killing Immunocytes
Application: 16/044,347 →
Publication: US 2019/0000879
Canine Autologous Immunotherapy Using Dendritic Cell Induced Cancer Killing Immunocytes
Application: 15/225,484 →
Publication: US 2017/0029775
Related Assignments (7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 15, 2018
From: KOOS, DAVID; ICHIM, THOMAS
To: ZANDER THERAPEUTICS, INC.
Reel/Frame 046105/0286 →
Assignment of Assignor's Interest Aug 8, 2018
From: LANDER, HARRY M.; KOOS, DAVID R.
To: ZANDER THERAPEUTICS, INC.
Reel/Frame 046590/0077 →
Assignment of Assignor's Interest Aug 8, 2018
From: LANDER, HARRY M.; KOOS, DAVID R.
To: REGEN BIOPHARMA INC.
Reel/Frame 046590/0115 →
Assignment of Assignor's Interest Dec 14, 2018
From: REGEN BIOPHARMA, INC.
To: KCL THERAPEUTICS, INC
Reel/Frame 047782/0163 →
Assignment of Assignor's Interest Dec 18, 2018
From: KOOS, DAVID; ICHIM, THOMAS
To: ZANDER THERAPEUTICS, INC.
Reel/Frame 047807/0551 →
Assignment of Assignor's Interest Jul 9, 2019
From: KCL THERAPEUTICS, INC.
To: ZANDER THERAPEUTICS, INC.
Reel/Frame 049704/0669 →
Assignment of Assignor's Interest Jul 19, 2023
From: ZANDER BIOLOGICS, INC.
To: SYBLEU INC.
Reel/Frame 064319/0263 →